161
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data

, , , , , , , & show all
Pages 3349-3357 | Published online: 12 Oct 2018

References

  • MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med2006311e44217132052
  • HurdSThe impact of COPD on lung health worldwide: epidemiology and incidenceChest20001172 Suppl1S4S10673465
  • EinarsonTRBerezaBGNielsenTAvan LaerJHemelsMESystematic review of models used in economic analyses in moderate-to-severe asthma and COPDJ Med Econ201619431935526535917
  • MulpuruSMckayJRonksleyPEThavornKKobewkaDMForsterAJFactors contributing to high-cost hospital care for patients with COPDInt J Chron Obstruct Pulmon Dis20171298999528392683
  • DalalAAChristensenLLiuFRiedelAADirect costs of chronic obstructive pulmonary disease among managed care patientsInt J Chron Obstruct Pulmon Dis2010534134921037958
  • ChiangCHCost analysis of chronic obstructive pulmonary disease in a tertiary care setting in TaiwanRespirology200813568969418513247
  • HutchinsonABrandCIrvingLRobertsCThompsonPCampbellDAcute care costs of patients admitted for management of chronic obstructive pulmonary disease exacerbations: contribution of disease severity, infection and chronic heart failureIntern Med J201040536437120180870
  • Maleki-YazdiMRKellySMLamSYMarinMBarbeauMWalkerVThe burden of illness in patients with moderate to severe chronic obstructive pulmonary disease in CanadaCan Respir J201219531932423061077
  • FangXWangXBaiCCOPD in China: the burden and importance of proper managementChest2011139492092921467059
  • WangCXuJYangLChina Pulmonary Health Study GroupPrevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional studyLancet2018391101311706171729650248
  • ChenXWangNChenYXiaoTFuCXuBCosts of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four citiesInt J Chron Obstruct Pulmon Dis2016112625263227799761
  • CaiBCaiSChenRCuiLFengYGuTShiYExpert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People’s Republic of ChinaInt J Chron Obstruct Pulmon Dis2014938139524812503
  • LiuHWangNChenWHospitalization Trends in Adult Patients with COPD and Other Respiratory Diseases in Northeast China from 2005 to 2015Biomed Res Int2018201817
  • ZhuBWangYMingJChenWZhangLDisease burden of COPD in China: a systematic reviewInt J Chron Obstruct Pulmon Dis2018131353136429731623
  • From the Global Strategy for the Diagnosis, Management and Prevention of COPD [homepage on the Internet]Global Initiative for Chronic Obstructive Lung Disease Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/Accessed May 30, 2017
  • Chronic Obstructive Pulmonary Disease Group, Respiratory Disease Branch, Chinese Medical AssociationChinese Guidelines for the Diagnosis and Treatment of Chronic Obstructive Pulmonary Diseases (Revised 2013)Chin J Med Sci2014626780 Chinese
  • PereraPNArmstrongEPSherrillDLSkrepnekGHAcute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortalityCOPD20129213114122409371
  • PasqualeMKSunSXSongFHartnettHJStemkowskiSAImpact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare populationInt J Chron Obstruct Pulmon Dis2012775776423152680
  • ChenYHYaoWZCaiBQEconomic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary diseaseChin Med J2008121758759118466676
  • DenizSŞengülAAydemirYÇeldir EmreJÖzhanMHClinical factors and comorbidities affecting the cost of hospital-treated COPDInt J Chron Obstruct Pulmon Dis2016113023303027980399
  • OzkayaSFindikSAticiAGThe costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary diseaseClinicoecon Outcomes Res20113151821935328
  • MiravitllesMMurioCGuerreroTGisbertRDAFNE Study GroupDecisiones sobre Antibioticoterapia y Farmacoeconomía en la EPOC. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPDChest200212151449145512006427
  • GerdthamUGAnderssonLFEricssonAFactors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohortEur J Health Econ200910221722618853206
  • FilipskiMJZhangYChenKZMaking health insurance pro-poor: evidence from a household panel in rural ChinaBMC Health Serv Res201515121026017455
  • ZhangCLeiXStraussJZhaoYHealth Insurance and Health Care among the Mid-Aged and Older Chinese: Evidence from the National Baseline Survey of CHARLSHealth Econ201726443144926856894
  • HouJWLiKThe aging of the Chinese population and the cost of health careSoc Sci J2011483514526
  • ÖrnekTTorMAltınRClinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary diseaseInt J Med Sci20129428529022701335
  • MarchettiNCrinerGJAlbertRKPreventing acute exacerbations and hospital admissions in COPDChest201314351444145423648908
  • ElpernEHBehnerKGKlontzBWarrenWHSzidonJPKestenSLung volume reduction surgery: an analysis of hospital costsChest199811348968999554622
  • WoutersEFEconomic analysis of the Confronting COPD survey: an overview of resultsRespir Med200397Suppl CS3S14
  • TerzanoCColamestaVUnimBChronic obstructive pulmonary disease (COPD) exacerbation: impact of comorbidities on length and costs during hospitalizationEur Rev Med Pharmacol Sci201721163680368928925473
  • WangCXuJYangLChina Pulmonary Health Study GroupPrevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional studyLancet2018391101311706171729650248
  • CelliBRBarnesPJExacerbations of chronic obstructive pulmonary diseaseEur Respir J20072961224123817540785
  • AlbertRKConnettJBaileyWCAzithromycin for prevention of exacerbations of COPDN Engl J Med2011365868969821864166
  • StefanMSRothbergMBShiehMSPekowPSLindenauerPKAssociation between antibiotic treatment and outcomes in patients hospitalized with acute exacerbation of COPD treated with systemic steroidsChest20131431829022797691
  • FanningMMckeanMSeymourKPillansPScottIAdherence to guideline-based antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease in an Australian tertiary hospitalIntern Med J201444990391024963727
  • YıldırımFTürkMÖztürkCCosts of the Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease in a University HospitalEurasian J Pulmonol2015173171175
  • CurrieJLinWZhangWPatient knowledge and antibiotic abuse: Evidence from an audit study in ChinaJ Health Econ201130593394921733587
  • CurrieJLinWMengJAddressing antibiotic abuse in China: An experimental audit studyJ Dev Econ2014110395126949284
  • El MoussaouiRRoedeBMSpeelmanPBresserPPrinsJMBossuytPMShort-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studiesThorax200863541542218234905
  • HuiKPHewittABA simple pulmonary rehabilitation program improves health outcomes and reduces hospital utilization in patients with COPDChest20031241949712853508
  • SeemungalTAHurstJRWedzichaJAExacerbation rate, health status and mortality in COPD – a review of potential interventionsInt J Chron Obstruct Pulmon Dis2009420322319554195
  • GüellRCasanPBeldaJLong-term effects of outpatient rehabilitation of COPD: A randomized trialChest2000117497698310767227